期刊文献+

环孢素A壳聚糖纳米微粒防治增生性玻璃体视网膜病变 被引量:4

Antiproliferative effect of CyA-loaded chitosan nanoparticles on experimental proliferative vitreoretinopathy
下载PDF
导出
摘要 目的评价环孢素A(CsA)壳聚糖纳米微粒抑制增生性玻璃体视网膜病变(PVR)的有效性和安全性。方法20只健康中华大耳白兔制作的PVR动物模型随机分为4组:A组玻璃体腔内注入0.1mL平衡液,B组玻璃体腔内注入0.1mL壳聚糖溶液(含壳聚糖2mg),C组玻璃体腔内注入0.1mLCsA溶液(含CsA0.1mg),D组玻璃体腔内注入0.1mLCsA壳聚糖纳米粒(含CsA0.1mg)。以检眼镜、电生理、光镜和电镜观察视网膜变化情况。结果玻璃体腔注药2周及4周后D组PVR等级均明显较A、B、C三组轻,组间差异具有统计学意义(P<0.05);而A组与B组、B组与C组之间比较差异无统计学意义(P>0.05)。D组注药前与注药后4周暗适应闪光ERGb波振幅的差异无统计学意义(P>0.05);D组注药后视网膜组织病理及超微结构未发现明显异常。结论一次性兔眼玻璃体腔注入CsA壳聚糖纳米微粒(含CsA0.1mg)能明显抑制或延缓PVR的发生,并具有生物相容性及安全性。 Objective This study was to evaluate the anti-proliferative effect and safety of cyclosporine A (CyA)-loaded chitosan (CS) nanoparticles in the treatment of proliferative vitreoretinopathy(PVR). Methods Platelet-rich plasma (PRP) was intravitreally injected to induce the experimental PVR in 20 white rabbits. The experimental rabbits were assigned to 4 groups. 0. 1 mL of BSS was injected into vitreous cavity in group A,and 0. 1 mL (2 mg) of CS solution was used in group B and CyA solution 0. 1 mL (CyA 0. 1 mg) in group C and CyA-loaded CS nanoparticles 0. 1 mL (CyA 0. 1 mg) in group D. After intravitreal injection, PVR was observed using ophthalmoscope at 1 day,3,7,14,21 and 28 days according to Fastenserg method. Scotopic flash ERG was recorded in the rabbits of group D preoperatively and 28 days after injection. Histopathological examination was performed in group D under the transmission electron microscope. Results The grading of PVR in group D was statistically lower than that in group A ( Z = 3. 724, P = 0. 000) , group B ( Z = 3.411, P = 0. 001 ) and group C ( Z = 3.180, P = 0. 002) on the 14th and 28th day, respectively( P 〈 0. 05 ). However, there was no significant difference in PVR grade between group A and group B(Z=1.594,P=0.110 1) or group B and group C(Z=1.681,P=0. 093).No any evident changes were found in b wave amplitude( 153.3 ± 17.9 μV in preinjection and 146.7 ± 19.2 μV in postinjection, t = - 0. 283, P = 0. 549 ) , histopathology or ultrastructure among various groups between before and after injection. Conclusion Intravitreal administration of CyA-loaded CS nanoparticles could predominantly inhibit the proliferative changes of experimental PVR induced by platelet-rich plasma. A dose of 0. 1 mg CyA-loaded CS nanoparticles is safe to retina of experimental rabbits.
出处 《眼科研究》 CSCD 北大核心 2007年第12期946-949,共4页 Chinese Ophthalmic Research
关键词 壳聚糖 纳米微粒 环孢素A 增生性玻璃体视网膜病变 chitosan nanoparticles cyclosporine A proliferative vitreoretinopathy
  • 相关文献

参考文献9

  • 1曹景泰,武丽,张惠蓉,梁晔,李凤云.增殖性视网膜病变玻璃体切割物的细胞学及免疫组化研究[J].中华眼科杂志,1997,33(4):264-267. 被引量:9
  • 2Rodriguez E, Martinez V, Aragon J, et al. Clinical risk factors for postoperative proliferative vitreoretinopathy (PVR). A prospective study [ J ]. Arch Soc Esp Oftalmol,2003,78:91-97. 被引量:1
  • 3Pasteor JC. Proliferative vitreoretinopathy: an overview[ J]. Surv Ophthalmol, 1998,43: 3-18. 被引量:1
  • 4Lau DC, Wong KL, Hawang WS. Closporine toxicity on cultured rat microvascular endothelial cells[ J ]. Kidnet Int, 1989,35: 604-613. 被引量:1
  • 5Cortina P, Gomez-Lechon M J, Navea A, et al. Diclofenac sodium and closporine A inhibit human lens epithelial cell proliferation in culture[ J]. Graefe' s Arch Clin Exp Ophthalmol, 1997,235: 180-185. 被引量:1
  • 6Crafoord S, Algvere PV, Kopp ED, et al. Cyclosporine treatment of RPE allografts in the rabbit subretinal space[ J ]. Acta Ophthalmol Scand ,2000, 78:122-129. 被引量:1
  • 7Howling GI, Dettmar PW, Goddard PA, et al. The effect of chitin and chitosan on the proliferation of human skin fibroblasts and keratinocytes in vitro [ J ]. Biomaterials, 2001,22: 2959-2966. 被引量:1
  • 8Singla AK, Chawla M. Chitosan: some pharmaceutical and biological aspects-an update[ J ]. J Pharm Pharmacol,2001,53: 1047-1067. 被引量:1
  • 9Hartmann V, Keipert S. Physico-chemical, in vitro and in vivo characterization of polymers for ocular use [ J ]. Pharmazie, 2000, 55 : 440-443. 被引量:1

二级参考文献3

  • 1曹景泰,中华眼科杂志,1995年,31卷,122页 被引量:1
  • 2曹景泰,国外医学.眼科学分册,1994年,18卷,168页 被引量:1
  • 3刘彦仿,免疫组织化学,1990年,240页 被引量:1

共引文献8

同被引文献46

  • 1邓新国,胡世兴,张清炯,杨锦南,林少春,陈慷.葛根素腹腔注射在兔视网膜组织中的药动学研究[J].中草药,2004,35(12):1382-1384. 被引量:5
  • 2董晓光,徐玉梅,原公强,史伟云,谢立信,王身国.环孢素A缓释系统眼内植入治疗葡萄膜炎的实验研究[J].中华眼科杂志,2005,41(7):636-641. 被引量:10
  • 3The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS) : 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators [ J ]. Am J Ophthalmol, 2000,130 : 429-440. 被引量:1
  • 4Cordeiro MF, Chang L, Lira KS, et al. Modulating conjunctival wound healing [ J ]. Eye ( Lond ), 2000,14 ( Pt 3 B ) : 536-547. 被引量:1
  • 5Grotendorst GR. Connective tissue growth factor:a mediator of TGF-beta action on fibroblasts [ J ]. Cytokine Growth Factor Rev, 1997, 8 : 171-179. 被引量:1
  • 6Tomasek JJ,McRae J, Owens GK, et M. Regulation of[ alpha l-smooth muscle actin expression in granulation tissue myofibroblasts is dependent on the intronic CArG element and the transforming growth factor-[ beta ] 1 control element[ J]. Am J Pathol,2005,166 : 1343-1351. 被引量:1
  • 7Cordeiro MF. Role of transforming growth factor beta in conjunctival scarring[J]. Clin Sci(Lond) ,2003,104 : 181-187. 被引量:1
  • 8Zhu X,Li L,Zou L,et al. A novel aptamer targeting TGF-B receptor II inhibits transdifferentiation of human Tenon's fibroblasts into myofibroblast [J]. Invest Ophthalmol Vis Sci ,2012,53 : 6897-6903. 被引量:1
  • 9Stein CA. Phosphorothioate antisense oligodeoxynucleotides: questions of specificity [ J ]. Trends in Biotechnol, 1996,14 : 147-149. 被引量:1
  • 10Urban-Klein B, Werth S, Abuharbeid S, et al. RNAi-mediated gene- targeting through systemic application of polyethylenimine (PEI)- complexed siRNA in vivo[ J]. Gene Ther,2005,12 : 461-466. 被引量:1

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部